Standard BioTools

Standard BioTools 是一家在股票代码 FLDM (US) 下上市的公司。

他们在：

• 医疗设备50%
• 生物技术50%

涉及Standard BioTools的并购和融资。

• Standard BioTools and SomaLogic have merged  (公布2024一月5号)..
• SomaLogic and Standard BioTools have announced they will merge  (公布2023十月6号)..

查看带有其 44 名主要高管的组织结构图

Standard BioTools 搜索最多的简介

• Michael Egholm, Chief Executive Officer and President
• Tom Carey, Chairman of the Board
• Kathy Hibbs, Director

高管在Standard BioTools变化

• Adam Taich 曾任 Interim Chief Executive Officer, SomaLogic, 现升职为 Chief Strategy Officer  (新闻发布的2024一月8号).
• Shane Bowen 曾任 Chief Research and Development Officer SomaLogic, 现升职为 Chief Technology Officer  (新闻发布的2024一月8号).
• Carlos Paya, Chairman of the Board, 已经离开公司  (新闻发布的2024一月7号).

更多的变化在％s

创建提醒
跟踪 Standard BioTools 的高管变动

Standard BioTools 拥有 977 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• Medigus将在Apr 12, 2024将其名称改为Xylo Technologies。 (公布2024四月12号).
• Johnson & Johnson has announced the acquisition of Shockwave Medical  (公布2024四月6号).
• Carlsmed 刚刚宣布为 52 筹款数百万美元。 (公布2024三月22号).

医疗设备 行业的其他推荐联系人

• Thermo Fisher Scientific 企业 Marc Casper - Chairman of the Board, President and Chief Executive Officer
• Philips 企业 Roy Jakobs - President and Chief Executive Officer
• Bruker 企业 Robert Rosenthal - Director

了解更多有关医疗设备行业的信息 >

Standard BioTools 的最新新闻稿

• Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results | Standard BioTools Inc.
• Press Releases | Standard BioTools Inc.
• Standard BioTools Announces First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging | Fluidigm Corporation
• Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fluidigm Corporation
• Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. | Fluidigm Corporation
• Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion | Fluidigm Corporation
• Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global | Fluidigm Corporation
• Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution | Fluidigm Corporation
• View more press releases Close

关于 Standard BioTools 的社交媒体

• Standard BioTools 在 维基百科、谷歌新闻 和 雅虎财经
• Standard BioTools 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Michael Egholm

致电Standard BioTools，电话：+1 650...

查看组织结构图

Register to receive your alert

报告错误